Thromb Haemost 1998; 79(01): 235
DOI: 10.1055/s-0037-1614253
Letters to the Editor
Schattauer GmbH

Superior Sagittal Sinus Thrombosis in a Patient Heterozygous for the Novel 20210 A Allele of the Prothrombin Gene

B. R. Bloem
1   From the Departments of Neurology and Hemostasis and Thrombosis Research Centre, Leiden University Medical Centre, The Netherlands
,
M. J. A. M. van Putten
1   From the Departments of Neurology and Hemostasis and Thrombosis Research Centre, Leiden University Medical Centre, The Netherlands
,
F. J. M. v. d. Meer
1   From the Departments of Neurology and Hemostasis and Thrombosis Research Centre, Leiden University Medical Centre, The Netherlands
,
J. J. van Hilten
1   From the Departments of Neurology and Hemostasis and Thrombosis Research Centre, Leiden University Medical Centre, The Netherlands
,
R. M. Bertina
1   From the Departments of Neurology and Hemostasis and Thrombosis Research Centre, Leiden University Medical Centre, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 02 June 1997

Accepted after revision 26 August 1997

Publication Date:
08 December 2017 (online)

 

 
  • References

  • 1 Cantú C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium.. Stroke 1993; 24: 1880-4.
  • 2 Heistinger M, Rumpl E, Illiasch H, Türk H, Kyrle PA, Lechner K, Pabinger I. Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature.. Ann Haematol 1992; 64: 105-9.
  • 3 Brey RL, Coull BM. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.. Stroke 1996; 27: 1719-20.
  • 4 Poort SR, Roosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.. Blood 1996; 88: 3698-703.
  • 5 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Roosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.. Lancet 1994; 344: 1453-7.